
Chemed: Reaffirm Buy After Upsides To EPS Guidance, ROIC
LPETTET/E+ via Getty Images Investment Summary Following our recent appraisal on Viemed Healthcare we also clarified our buy thesis on Chemed Corporation (NYSE:CHE). In our last publication on CHE, we reported CHE demonstrated a multitude […]